We are live on
!
Find out more
SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
47 hedge funds and large institutions have $89.6M invested in scPharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 13 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
23% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 13
0.55% less ownership
Funds ownership: 62.57% → 62.02% (-0.55%)
8% less funds holding
Funds holding: 51 → 47 (-4)
30% less capital invested
Capital invested by funds: $127M → $89.6M (-$37.7M)
31% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 13
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
47
Holders Change
-4
Holders Change %
-7.84%
% of All Funds
0.83%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
9
Increased
16
Reduced
13
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
+$492K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$355K |
| 3 |
ZIM
Zacks Investment Management
Chicago,
Illinois
|
+$302K |
| 4 |
VF
Virtu Financial
New York
|
+$285K |
| 5 |
Bank of New York Mellon
New York
|
+$256K |
